Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Impacts of host lipid composition on antimicrobial susceptibilities of Staphylococcus aureus

Award Number: R01AI173144
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 12/14/2022
PERIOD OF PERFORMANCE END DATE: 11/30/2027

Group Awards By:

View Award Description

Impacts of host lipid composition on antimicrobial susceptibilities of Staphylococcus aureus - Although the CDC's 2019 report on Antibiotic Resistance Threats in U.S. shows that methicillin-resistant Staphylococcus aureus (MRSA) cases have declined, nearly 85% of all deaths attributed to antibiotic resistance between 2005 and 2016 were the result of MRSA infections. Bloodstream infections from community-acquired MRSA have declined less sharply than hospital-acquired MRSA during this time (-17% and -6.9%, respectively), whereas cases of community-associated methicillin-susceptible S. aureus (MSSA) have risen nearly 4%. Nearly half of all health-care-associated infections are now attributed to MSSA rather than MRSA. At the same time, MSSA and MRSA are being identified as the cause of infective endocarditis with greater frequency. The changing dynamics of S. aureus infections demonstrate the critical need to better our understanding of its pathogenesis in order to develop new approaches for prevention and treatment. One of the competitive advantages S. aureus has within the infection site is its ability to scavenge host-derived fatty acids to satisfy its own lipid biosynthesis needs. The mechanisms of the fatty acid kinase pathway are well-documented for monounsaturated fatty acids like oleic acid. However, the fatty acid content of the human body varies dramatically between different organs and tissues. Despite their prevalence in the human body, we have overlooked the role of host-derived saturated, straight-chain fatty acids (SCFAs) in investigations of the fatty acid kinase pathway. Our long-term goal is to increase the efficacy of existing antibacterial therapies by purposefully and selectively remodeling the staphylococcal membrane during infection. The overall objective for this application is to define the lipid composition of S. aureus within the complex environment of the mammalian host and identify the impacts of host-derived FAs on the antimicrobial susceptibilities of S. aureus. Our central hypothesis is that the S. aureus membrane mimics the fatty acyl composition of the infection site to a greater extent than previously thought and that the resulting impacts on membrane physiology modify the tolerance of S. aureus to antimicrobials. The rationale for this project is that more effective antimicrobial treatment regimens will be developed by accounting for or exploiting the lipid composition of S. aureus when residing within the mammalian host. In Aim 1, we will determine the prevalence and fate of mammalian-derived saturated and unsaturated fatty acids using advanced liquid chromatography-mass spectrometry-based lipidomics. In Aim 2, we will identify the impact of S. aureus' use of exogenous fatty acids on its membrane physiology and cell morphology. In Aim 3, we will test the hypothesis that host-derived fatty acids can influence antibiotic tolerances of S. aureus in vitro and in vivo. We expect that the results of our research will prompt greater appreciation and consideration of host-derived fatty acids as modulators of antibiotic susceptibility and tolerance, which will have the positive impact of reducing poor clinical outcomes from S. aureus infections.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $477,462 )
2026	2026	UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.	310 E CAMPUS RD RM 409	ATHENS	GA	30602	CLARKE	USA	Allergy and Infectious Diseases Research	000	4	12/8/2025	NON-COMPETING CONTINUATION	$477,462
														Subtotal = $477,462

Issue Date FY: 2025 ( Subtotal = $471,568 )
2025	2025	UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.	310 E CAMPUS RD RM 409	ATHENS	GA	30602	CLARKE	USA	Allergy and Infectious Diseases Research	000	3	11/4/2024	NON-COMPETING CONTINUATION	$471,568
														Subtotal = $471,568

Issue Date FY: 2024 ( Subtotal = $457,744 )
2024	2024	UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.	310 E CAMPUS RD RM 409	ATHENS	GA	30602	CLARKE	USA	Allergy and Infectious Diseases Research	001	2	5/14/2024	NON-COMPETING CONTINUATION	$45,775
2024	2024	UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.	310 E CAMPUS RD RM 409	ATHENS	GA	30602	CLARKE	USA	Allergy and Infectious Diseases Research	000	2	11/1/2023	NON-COMPETING CONTINUATION	$411,969
														Subtotal = $457,744

Issue Date FY: 2023 ( Subtotal = $418,670 )
2023	2023	UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.	310 EAST CAMPUS RD TUCKER HALL ROOM 409	ATHENS	GA	30602	CLARKE	USA	Allergy and Infectious Diseases Research	000	1	12/14/2022	NEW	$418,670
														Subtotal = $418,670

Grand Total All Awards = $1,825,444

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Impacts of host lipid composition on antimicrobial susceptibilities of Staphylococcus aureus

Award Number: R01AI173144

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 12/14/2022

PERIOD OF PERFORMANCE END DATE: 11/30/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer